Manning & Napier Group, LLC Boston Scientific Corp Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Manning & Napier Group, LLC holds 258,118 shares of BSX stock, worth $25.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

258,118

Previous 299,575 13.84%

Holding current value

$25.5 Million

Previous $17.3 Million 2.07%

% of portfolio

0.2%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$57.6 - $68.62 $2.39 Million - $2.84 Million	-41,457 Reduced 13.84%	258,118 $17.7 Million
Q4 2023 Jan 19, 2024	SELL	$48.64 - $57.81 $62,113 - $73,823	-1,277 Reduced 0.42%	299,575 $17.3 Million
Q3 2023 Oct 20, 2023	SELL	$50.19 - $54.68 $8.13 Million - $8.86 Million	-162,021 Reduced 35.0%	300,852 $15.9 Million
Q2 2023 Jul 26, 2023	SELL	$49.72 - $54.64 $264,808 - $291,012	-5,326 Reduced 1.14%	462,873 $25 Million
Q1 2023 Apr 17, 2023	BUY	$45.09 - $50.03 $4.6 Million - $5.1 Million	102,028 Added 27.86%	468,199 $23.4 Million
Q4 2022 Jan 26, 2023	SELL	$39.56 - $47.22 $1.57 Million - $1.87 Million	-39,647 Reduced 9.77%	366,171 $0
Q3 2022 Oct 18, 2022	SELL	$36.71 - $109.66 $21,255 - $63,493	-579 Reduced 0.14%	405,818 $15.7 Million
Q2 2022 Jul 12, 2022	SELL	$35.24 - $47.1 $887,554 - $1.19 Million	-25,186 Reduced 5.84%	406,397 $15.1 Million
Q1 2022 Apr 19, 2022	SELL	$40.9 - $45.1 $490,800 - $541,200	-12,000 Reduced 2.71%	431,583 $19.1 Million
Q4 2021 Jan 27, 2022	SELL	$38.07 - $44.87 $33,501 - $39,485	-880 Reduced 0.2%	443,583 $18.8 Million
Q3 2021 Oct 14, 2021	SELL	$41.23 - $45.88 $90,912 - $101,165	-2,205 Reduced 0.49%	444,463 $19.3 Million
Q2 2021 Jul 19, 2021	SELL	$38.58 - $44.24 $537,457 - $616,307	-13,931 Reduced 3.02%	446,668 $19.1 Million
Q1 2021 Apr 28, 2021	BUY	$35.27 - $39.67 $1.12 Million - $1.26 Million	31,853 Added 7.43%	460,599 $17.8 Million
Q4 2020 Jan 20, 2021	BUY	$33.15 - $41.97 $1.49 Million - $1.88 Million	44,862 Added 11.69%	428,746 $15.4 Million
Q3 2020 Oct 29, 2020	SELL	$34.44 - $42.23 $194,276 - $238,219	-5,641 Reduced 1.45%	383,884 $14.7 Million
Q2 2020 Jul 10, 2020	BUY	$30.19 - $39.11 $463,990 - $601,081	15,369 Added 4.11%	389,525 $13.7 Million
Q1 2020 Apr 13, 2020	SELL	$25.83 - $45.71 $3.13 Million - $5.54 Million	-121,225 Reduced 24.47%	374,156 $12.2 Million
Q4 2019 Jan 10, 2020	SELL	$37.87 - $45.37 $1.52 Million - $1.82 Million	-40,095 Reduced 7.49%	495,381 $22.4 Million
Q3 2019 Oct 10, 2019	SELL	$40.31 - $43.45 $2.84 Million - $3.06 Million	-70,410 Reduced 11.62%	535,476 $21.8 Million
Q2 2019 Jul 24, 2019	BUY	$34.91 - $42.98 $21.2 Million - $26 Million	605,886 New	605,886 $26 Million

Others Institutions Holding BSX

# of Institutions

1,559

Shares Held

1.18B

Call Options Held

6.78M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $141B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account

Manning & Napier Group, LLC Boston Scientific Corp Transaction History